Celsius Holdings, Inc. (CELH) is likely to register a top and bottom-line decline when it reports first-quarter 2025 earnings on May 6.The Zacks Consensus Estimate for revenues is pegged at $341.7 million, which indicates almost a 4% decrease from the year-ago period's level.Although the consensus mark for quarterly earnings has moved up a penny in the past 30 days to 20 cents per share, the projection indicates a 25.9% decrease from the year-ago quarter’s figure. CELH has a trailing four-quarter negative e ...

Core Viewpoint - Crescent Energy Company (CRGY) is expected to report first-quarter 2025 results on May 5, with earnings estimated at 47 cents per share, reflecting a 2.2% increase year-over-year, and revenues projected at $937.1 million, indicating a 42.5% rise from the previous year [1][3]. Financial Performance - CRGY has consistently beaten consensus earnings estimates in the past four quarters, with an average surprise of 82.4% [3]. - The company currently has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell), suggesting a lower likelihood of an earnings beat this time [4]. - The average daily sales volume of oil for the March quarter is estimated at 103.36 MBbls/d, significantly higher than 70 MBbls/d in the prior-year quarter [6]. Market Context - The stock has decreased by 15.9% over the past year, outperforming the industry average decline of 27.3% [8]. - CRGY's trailing 12-month EV/EBITDA ratio is 3.02, indicating it is trading at a discount compared to the industry average of 10.63 [11]. Strategic Developments - Since the end of 2023, CRGY has completed five acquisitions totaling over $3 billion, enhancing its presence in the Eagle Ford shale play [14]. - The company's reliance on acquisitions for growth raises concerns about its organic growth capabilities, which are essential for sustainable operations [14].

Core Insights - KKR & Co. Inc. reported an adjusted net income per share of $1.15 for Q1 2025, exceeding the Zacks Consensus Estimate of $1.13 and up from $0.97 in the prior-year quarter [1] - The company's total revenues reached $1.2 billion, a 21.6% increase year-over-year, driven by higher management fees and transaction fees, surpassing the Zacks Consensus Estimate of $1.19 billion [3] - Total assets under management (AUM) grew 14.8% year-over-year to $664.3 billion, with fee-paying AUM increasing 11.7% to $526 billion [4] Financial Performance - KKR's total operating earnings rose 15.6% year-over-year to $1.11 billion, supported by a 23% increase in fee-related earnings to $822.6 million [5] - The net loss attributable to the company on a GAAP basis was $185.9 million, contrasting with a net income of $682.2 million in the same quarter last year [2] - Total segment expenses increased by 18.8% to $377.5 million, reflecting the company's ongoing expansion and operational costs [3] Market Position and Outlook - KKR is expected to leverage its strong fundraising capabilities to capitalize on lucrative investment opportunities in the future [6] - The company is experiencing significant growth in fee-related and total operating earnings, although elevated expenses due to global expansion and a challenging operating environment are concerns [6] - KKR currently holds a Zacks Rank of 5 (Strong Sell), indicating market sentiment towards the stock [7]

Core Viewpoint - Alliant Energy (LNT) is set to release its first-quarter 2025 results on May 8, following a previous negative earnings surprise of 2.9% in the last quarter [1] Group 1: Factors Impacting Q1 Performance - The company placed two solar projects with a combined capacity of 200 megawatts (MW) into service during Q4 2024, along with the 50-MW Creston Solar Project, which is expected to power approximately 40,000 homes annually, likely boosting financial performance in Q1 [2] - An order from the IUC authorized annual base rate increases of $185 million for retail electric customers and $10 million for retail gas customers, effective from October 2024 through September 2025, which is expected to enhance revenue in the upcoming quarter [3] - Severe storms in March 2025 caused significant power outages and disruptions, potentially leading to higher operating expenses for restoration, which may offset some positive impacts on financial performance [4] Group 2: Q1 Expectations - The Zacks Consensus Estimate for earnings is 57 cents per share, reflecting a year-over-year decline of 8.1% [5] - The Zacks Consensus Estimate for revenues is $1.13 billion, indicating a year-over-year increase of 9.2% [5] - Total electricity delivered is estimated at 8,442.6 megawatt-hours (MWh), representing a 1.1% year-over-year increase [5] Group 3: Earnings Prediction - The company's Earnings ESP is +9.88%, suggesting a favorable outlook for an earnings beat this quarter [6] - Alliant Energy currently holds a Zacks Rank of 3, indicating a neutral outlook [7]

Core Viewpoint - Avnet reported a decline in earnings and sales for the third quarter of fiscal 2025, reflecting broader market pressures and margin contraction across its segments [1][2]. Financial Performance - Earnings per share for Q3 fiscal 2025 were 84 cents, exceeding the Zacks Consensus Estimate by 16.7%, but down 23.6% year-over-year [1]. - Net sales reached $5.32 billion, surpassing the Zacks Consensus Estimate by 0.46%, yet decreased by 6% compared to the same quarter last year [1]. - Adjusted operating income was $152.7 million, a decline of 24.7% year-over-year [4]. Segment Performance - The Electronic Components segment saw revenues decline by 5.7% year-over-year to $4.95 billion, slightly below estimates [3]. - Farnell sales decreased by 10.1% year-over-year but increased by 6.1% sequentially to $366.7 million, exceeding estimates [3]. Regional Sales - Year-over-year sales increased by 13% in Asia to $2.48 billion, while EMEA sales fell by 24.1% to $1.56 billion and Americas sales decreased by 9.2% to $1.27 billion [4]. Margin Analysis - Adjusted operating margin shrank by 70 basis points to 2.9% compared to the previous year [5]. - The Electronic Components adjusted operating margin contracted by 65 basis points to 3.5%, while Farnell's margin declined by 101 basis points to 3% [5]. Balance Sheet and Cash Flow - As of March 29, 2025, cash and cash equivalents were $188.9 million, up from $172.1 million at the end of the previous quarter [6]. - Long-term debt decreased to $2.49 billion from $2.57 billion in the prior quarter [6]. - The company generated $141 million in cash from operating activities during Q3 [6]. Shareholder Returns - Avnet repurchased approximately $101 million worth of shares, representing 2.3% of shares outstanding, and returned $28 million to shareholders in dividends [7]. Q4 Guidance - For Q4 fiscal 2025, Avnet anticipates revenues between $5.15 billion and $5.45 billion, with a midpoint of $5.30 billion, indicating a year-over-year decline of 6.41% [8]. - Expected non-GAAP earnings are projected to be between 65 and 75 cents per share, suggesting a year-over-year decline of 34.6% [9].

Core Insights - Gen Digital Inc. (GEN) is set to report its fourth-quarter fiscal 2025 results on May 6, with expected non-GAAP revenues between $990 million and $1,005 million, reflecting a year-over-year growth of 3.2% [1] - The company anticipates non-GAAP earnings per share in the range of 57-59 cents, with a consensus estimate of 58 cents, indicating a year-over-year increase of 9.4% [2] Revenue Expectations - The Consumer Security segment's revenue is estimated at $632.9 million, showing a year-over-year increase of 1.9%, while the Identity and Information Protection division is projected to generate $354 million, reflecting a growth of 4.1% [4] - The increase in average direct paying customers by 400,000 to 40.1 million in the third quarter is expected to positively influence revenue growth [3] Market Dynamics - The demand for cybersecurity products has surged due to a significant rise in global hacking incidents, which has likely benefited Gen Digital's performance [3] - The launch of Norton Small Business Premium, a comprehensive cybersecurity solution, is anticipated to have contributed to sales growth in the upcoming quarter [4] Challenges - The company's performance may be negatively impacted by a decline in IT spending, driven by high interest rates and inflation affecting consumer spending [6] - Enterprises are reportedly deferring substantial IT investments due to a weakening global economy and ongoing macroeconomic and geopolitical challenges [6] Earnings Prediction - Current analysis indicates that Gen Digital does not have a strong likelihood of beating earnings expectations, with an Earnings ESP of -1.16% and a Zacks Rank of 4 (Sell) [7]

Core Viewpoint - TreeHouse Foods, Inc. (THS) is expected to report declines in both revenue and adjusted loss for the first quarter of 2025, with revenue estimated at $789.6 million, reflecting a 3.8% decrease year-over-year [1] Group 1: Performance Expectations - The Zacks Consensus Estimate for quarterly adjusted loss has been narrowed to 21 cents per share, indicating a significant decline from the previous year's figure [1] - The company has a trailing four-quarter earnings surprise average of 17.8%, but in the last reported quarter, it lagged the Zacks Consensus Estimate by 2.1% [1] Group 2: Factors Influencing Performance - Ongoing operational disruptions and macroeconomic headwinds are likely to negatively impact THS's first-quarter performance, particularly due to a frozen griddle product recall at the Brantford facility [2] - Weak private label consumption trends amid broader consumer spending pressures are expected to further affect performance [3] - Strategic margin management actions, including exiting low-margin contracts, are anticipated to have intentionally reduced volume, compounding negative impacts on revenue [3] Group 3: Profitability Challenges - Lower volumes are hurting operating leverage, making it difficult for the company to absorb fixed costs, which compresses gross margin [4] - One-time recall-related costs, including plant sanitation and restart costs, are also exerting pressure on profitability [4] Group 4: Guidance and Initiatives - For the first quarter, TreeHouse Foods expects adjusted net sales of at least $792 million and adjusted EBITDA of at least $52 million, indicating potential gains from cost-saving initiatives [5] - The company is focused on implementing the TreeHouse Management Operating System and other supply-chain initiatives to improve execution and enhance margin performance [6] Group 5: Earnings Prediction - The Zacks model predicts an earnings beat for TreeHouse Foods, supported by a positive Earnings ESP of +63.42% and a Zacks Rank of 3 (Hold) [7]

Core Viewpoint - Stryker Corporation is expected to report its first-quarter 2025 results on May 1, with earnings estimated at $2.73 per share, reflecting a year-over-year increase of 9.2% and revenues projected at $5.70 billion, indicating an 8.8% growth from the previous year [1][2]. Group 1: Performance Drivers - The anticipated strong performance in the first quarter is attributed to robust sales in the U.S. market across various segments, including Instruments, Medical, Endoscopy, Trauma and Extremities, and Mako [3]. - The MedSurg and Neurotechnology segment experienced significant sales growth in the previous quarter, driven by the Surgical Technologies and orthopedic implants businesses, which is expected to continue [4]. - Recent product launches, including the next generation of SurgiCount+ and the Oculan Lighting Platform, are likely to contribute to additional sales in the first quarter [5]. Group 2: Product Portfolio and Acquisitions - The commercialization of the Pangea Plating system and strong sales of the LIFEPAK 35 defibrillator are expected to have positively impacted first-quarter results [6]. - New products like the Osteotomy Truss System and Ankle Truss System are anticipated to enhance the Foot & Ankle portfolio, improving surgical precision and patient outcomes [7]. - Stryker has completed five acquisitions in the latter half of 2024, which are expected to be accretive to quarterly results, enhancing its product offerings in various medical fields [8]. Group 3: Sales Estimates - Sales estimates for the MedSurg and Neurotechnology segments are projected at $3.75 billion, while Orthopaedics & Spine segments are estimated at $2.57 billion. U.S. sales are expected to be $4.74 billion, with international sales at $1.59 billion [9]. Group 4: Market Challenges - Ongoing challenges in China due to volume-based procurement policies and rising tariffs may partially offset international growth, although Stryker is addressing inflationary pressures and has recognized improved pricing and reduced cost pressures [10].

Diamondback Energy (FANG) is set to release first-quarter 2025 results on May 5. The current Zacks Consensus Estimate for the to-be-reported quarter is a profit of $4 per share on revenues of $3.7 billion.Let’s delve into the factors that might have influenced the Permian-focused oil and gas producer’s performance in the March quarter. But it’s worth taking a look at FANG’s previous-quarter performance first.Highlights of Q4 Earnings & Surprise HistoryIn the last reported quarter, this Midland, TX-based ups ...

Core Viewpoint - Cardinal Health, Inc. is set to report its third-quarter fiscal 2025 results, with expectations of continued strong performance driven by recent acquisitions and robust pharmaceutical demand [1][10]. Group 1: Recent Acquisitions and Strategic Growth - The acquisition of Integrated Oncology Network (ION) in December 2024 is expected to enhance Cardinal Health's oncology services through integration into its Navista practice [2]. - In November, Cardinal Health announced plans to acquire a majority stake in GI Alliance and Advanced Diabetes Supply Group, with the acquisition of GI Alliance completed in January, supporting its multi-specialty growth strategy [3]. - These acquisitions are anticipated to positively impact the Pharmaceutical and Specialty Solutions segment, although the full effects may be realized by the end of the fiscal year [4]. Group 2: Financial Performance and Estimates - For the third quarter, the Zacks Consensus Estimate for revenues is $55.03 billion, reflecting a 0.2% increase year-over-year, while the EPS estimate is $2.15, indicating a 3.4% increase from the prior year [10]. - The Pharmaceutical and Specialty Solutions segment is projected to generate revenues of $49.41 billion, down 2.4% year-over-year, influenced by customer contract expirations [6][5]. Group 3: Product Launches and Innovations - The Nuclear and Precision Health Solutions business has begun weekly production of actinium-225 (Ac-225), enhancing the availability of investigational therapeutic drug products [7]. - The launch of the Kendall SCD SmartFlow Compression System is expected to boost sales in the Global Medical Products and Distribution segment [8]. Group 4: Market Performance and Valuation - Cardinal Health's shares have increased by 8.3% over the past three months, outperforming the Medical - Dental Supplies sector and other peers [13][17]. - The company's forward 12-month price-to-earnings (P/E) ratio is 15.7X, which is below the industry average of 16.7X, indicating potential for growth relative to its peers [18][19]. Group 5: Long-Term Growth Prospects - Cardinal Health is constructing a new at-Home Solutions distribution center in Fort Worth, TX, expected to be operational by summer 2025, which will enhance its distribution capabilities [20]. - The opening of a new distribution center in Boylston, MA, is anticipated to strengthen supply chain resiliency and improve service for New England customers [21].